GRAIL's Galleri MCED test did not significantly reduce late-stage cancers in a large NHS-Galleri trial, with only a modest improvement observed in stage IV cases.
- In the news
Prostate Cancer Diagnosis and Treatment
Moving in Cancer Discovery.
- Moved this week
- 1
Rebuilt
Moved this week
Latest in Prostate Cancer Diagnosis and Treatment
Newest first · last 60 days
Integrated mutational signatures in prostate cancer reveal eight key footprints explaining 85% of genomes and link to clinical outcomes.
- Open access
- 1 cites
Perioperative ADT plus apalutamide improves pathological response and metastasis-free survival in high-risk prostate cancer patients undergoing prostatectomy, with 8.9% achieving complete response.
- 26 cites
Follow this area in the app
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4